Your browser doesn't support javascript.
loading
Hypothalamic POMC neurons promote cannabinoid-induced feeding.
Koch, Marco; Varela, Luis; Kim, Jae Geun; Kim, Jung Dae; Hernández-Nuño, Francisco; Simonds, Stephanie E; Castorena, Carlos M; Vianna, Claudia R; Elmquist, Joel K; Morozov, Yury M; Rakic, Pasko; Bechmann, Ingo; Cowley, Michael A; Szigeti-Buck, Klara; Dietrich, Marcelo O; Gao, Xiao-Bing; Diano, Sabrina; Horvath, Tamas L.
Afiliação
  • Koch M; 1] Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA [2] Institute of Anatomy, University of Leipzig, 04103 Leipzig, Germany.
  • Varela L; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Kim JG; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Kim JD; 1] Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA [2] Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connectic
  • Hernández-Nuño F; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Simonds SE; Obesity &Diabetes Institute, Department of Physiology, Monash University, Clayton, Victoria 3800, Australia.
  • Castorena CM; Division of Endocrinology &Metabolism, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
  • Vianna CR; Division of Endocrinology &Metabolism, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
  • Elmquist JK; Division of Endocrinology &Metabolism, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
  • Morozov YM; Department of Neurobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Rakic P; 1] Department of Neurobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA [2] Kavli Institute for Neuroscience, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Bechmann I; Institute of Anatomy, University of Leipzig, 04103 Leipzig, Germany.
  • Cowley MA; Obesity &Diabetes Institute, Department of Physiology, Monash University, Clayton, Victoria 3800, Australia.
  • Szigeti-Buck K; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Dietrich MO; 1] Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA [2] Department of Neurobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Gao XB; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Diano S; 1] Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA [2] Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connectic
  • Horvath TL; 1] Program in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA [2] Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connectic
Nature ; 519(7541): 45-50, 2015 Mar 05.
Article em En | MEDLINE | ID: mdl-25707796
ABSTRACT
Hypothalamic pro-opiomelanocortin (POMC) neurons promote satiety. Cannabinoid receptor 1 (CB1R) is critical for the central regulation of food intake. Here we test whether CB1R-controlled feeding in sated mice is paralleled by decreased activity of POMC neurons. We show that chemical promotion of CB1R activity increases feeding, and notably, CB1R activation also promotes neuronal activity of POMC cells. This paradoxical increase in POMC activity was crucial for CB1R-induced feeding, because designer-receptors-exclusively-activated-by-designer-drugs (DREADD)-mediated inhibition of POMC neurons diminishes, whereas DREADD-mediated activation of POMC neurons enhances CB1R-driven feeding. The Pomc gene encodes both the anorexigenic peptide α-melanocyte-stimulating hormone, and the opioid peptide ß-endorphin. CB1R activation selectively increases ß-endorphin but not α-melanocyte-stimulating hormone release in the hypothalamus, and systemic or hypothalamic administration of the opioid receptor antagonist naloxone blocks acute CB1R-induced feeding. These processes involve mitochondrial adaptations that, when blocked, abolish CB1R-induced cellular responses and feeding. Together, these results uncover a previously unsuspected role of POMC neurons in the promotion of feeding by cannabinoids.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pró-Opiomelanocortina / Canabinoides / Ingestão de Alimentos / Hipotálamo / Neurônios Limite: Animals Idioma: En Revista: Nature Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pró-Opiomelanocortina / Canabinoides / Ingestão de Alimentos / Hipotálamo / Neurônios Limite: Animals Idioma: En Revista: Nature Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha